Coherus BioSciences Inc. (CHRS) Fell -5.61% or -0.52 To Price $8.75 On Thursday


Coherus BioSciences Inc. (CHRS) fell -5.61% or -0.52 to $8.75. It is approximately 422723 shares traded, which is 56.69% compare to the average total volume 745700. The market cap of CHRS is $595.22 million. The year to date change is -8.54%. The 52 week price range is from $8.39 to $20.66. Price of CHRS have changed -2.32% during last week. It have changed -19.88% over last month, -42.06% over last 3 months, -38.61% over last 6 months and 0.22% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CHRS is 11.23. It is 28.34% above current price. The 200-day Moving Averages for CHRS is 14.43. It is 64.91% above current price. The 52-week High is 20.66. It is 136.11% from the current price. The 52-week Low is 8.39. It is -4.11% from current price.

There are some statistics of CHRS. It is has market cap $595.22 million. The share outstanding is 68.02 million. The average volume is 745700. The percent of top 15 Institution holding is 138.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CHRS is -570.97%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CHRS is -118.24%.


Tags:

Share this post